INDOCO logo

Indoco Remedies Limited Stock Price

NSEI:INDOCO Community·₹27.2b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author

INDOCO Share Price Performance

₹294.65
-42.00 (-12.48%)
22.5% undervalued intrinsic discount
₹380.00
Fair Value
₹294.65
-42.00 (-12.48%)
74.6% undervalued intrinsic discount
₹1,157.78
Fair Value
Price ₹294.65
ThewealthyinvestorbyDSAB ₹1,157.78
AnalystConsensusTarget ₹260.00
AnalystLowTarget ₹207.00

INDOCO Community Narratives

ThewealthyinvestorbyDSAB·
Fair Value ₹380 22.5% undervalued intrinsic discount

Indoco Remedies Will Benefit from India's Healthcare Growth

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystConsensusTarget·
Fair Value ₹260 13.3% overvalued intrinsic discount

Regulatory Challenges And Capacity Expansion Will Reshape Future Potential

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AnalystLowTarget·
Fair Value ₹207 42.3% overvalued intrinsic discount

US And EU Regulation Will Hamper Long-Term Profitability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent INDOCO News & Updates

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely

Sep 05
Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely

Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259

Jul 27
Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259

Indoco Remedies Limited (NSE:INDOCO) Soars 27% But It's A Story Of Risk Vs Reward

Jul 01
Indoco Remedies Limited (NSE:INDOCO) Soars 27% But It's A Story Of Risk Vs Reward

Indoco Remedies Limited Key Details

₹16.7b

Revenue

₹4.9b

Cost of Revenue

₹11.8b

Gross Profit

₹12.9b

Other Expenses

-₹1.1b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-12.16
Gross Margin
70.58%
Net Profit Margin
-6.71%
Debt/Equity Ratio
97.6%

Indoco Remedies Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued with reasonable growth potential.

1 Risk
3 Rewards

About INDOCO

Founded
1945
Employees
6000
CEO
Sundeep Bambolkar
WebsiteView website
www.indoco.com

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.9%
  • 3 Months: -1.2%
  • 1 Year: -3.8%
  • Year to Date: 1.2%
The market has climbed 1.9% in the last 7 days, lead by the Financials sector with a gain of 2.3%. In contrast, the market has seen a decline of 3.8% over the last 12 months. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›